GB604563A - Improvements in and relating to the purification of penicillin salts - Google Patents

Improvements in and relating to the purification of penicillin salts

Info

Publication number
GB604563A
GB604563A GB3203245A GB3203245A GB604563A GB 604563 A GB604563 A GB 604563A GB 3203245 A GB3203245 A GB 3203245A GB 3203245 A GB3203245 A GB 3203245A GB 604563 A GB604563 A GB 604563A
Authority
GB
United Kingdom
Prior art keywords
penicillin
salt
ether
solvent
sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3203245A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Laboratories Ltd
Original Assignee
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Laboratories Ltd filed Critical Glaxo Laboratories Ltd
Priority to GB3203245A priority Critical patent/GB604563A/en
Publication of GB604563A publication Critical patent/GB604563A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)

Abstract

Salts of penicillin of a high degree of purity are prepared by dissolving a crude metallic (preferably sodium or calcium) salt of penicillin (preferably of not less than 20 per cent purity) in water (preferably in such quantity as to give a concentration of about 1 per cent w/v.), acidifying (preferably to about pH 2.5) with a strong acid, and combining the liberated penicillin acid with one or more tertiary organic bases selected from N-alkylated piperidines, with or without one or more methyl groups as substituents on the carbon atoms of the ring, or N-alkylated pyrrolidines, with or without one or more methyl or ethyl groups (or both) as substituents on the carbon atoms of the ring, the total number of exocyclic carbon atoms in either case not exceeding 5. Preferably, the free penicillin is extracted, before combination with the base, into a suitable solvent (i.e. one into which penicillin can be extracted readily from acidified aqueous solution and which is relatively inert to penicillin, and in which the tertiary base salts of penicillin are relatively insoluble), preferably so as to give a concentration of penicillin therein of 0.25-5 per cent w/v, and advantageously after adding to the aqueous solution a highly soluble neutral inorganic salt commonly used for salting out purposes, and there is added to the extract a suitable secondary solvent (capable of retaining the tertiary base salts of the impurities in solution). As an alternative or in addition to adding the secondary solvent, the precipitate subsequently produced by the addition of at least (and usually considerably more than) one molar equivalent of the tertiary base or bases is washed with (or crystallized from) the secondary solvent or a mixture thereof with the first solvent, and may, if desired, be further purified by recrystallization from an organic solvent or mixture of solvents. To obtain a metal salt of penicillin of a similar high degree of purity, an aqueous solution of the tertiary base salt is treated with a mineral acid, the liberated penicillin is extracted into an organic solvent, and there is added to the extract an aqueous solution or suspension of a metallic hydroxide. In examples: (1) crude penicillin sodium or calcium salt is dissolved in ice-cold water with the addition of sodium chloride followed by ether and then by dilute phosphoric acid, the ether layer is separated the residue extracted with more ether, the combined ethered extracts filtered at -80 DEG C. and shaken with charcoal which is separated by filtration and eluted with ether, then acetone is added to the eluate, followed by a solution of N-ethyl-piperidine in ether, the precipitated salt is filtered off, washed with acetone, dried, and recrystallized if desired by dissolving in warm methylene chloride, adding acetone and then slowly adding carbon tetrachloride; the product may be converted into the pure sodium salt by dissolving it in ice-cold water, shaking with chloroform while adding dilute phosphoric acid, again extracting the aqueous layer with chloroform, neutralizing the combined extracts with aqueous sodium hydroxide, freeze-drying and crystallizing from acetone; (2) the ethereal solution obtained as in (1) is treated with N-n-propylpiperidine, either with the preliminary addition of acetone or with recrystallization of the precipitated salt therefrom; (3) crude penicillin calcium salt is treated as in (1) but using methyl isobutyl ketone instead of ether; (4) crude penicillin calcium salt is treated as in (1) but using methyl ethyl ketone as the secondary solvent and N-ethylhexahydro-a -picoline as the base; (5) the N-ethylpiperidine in (1) is replaced by N-ethylpyrrolidine. Amyl acetate is additionally specified as a suitable first solvent, and sodium nitrate, sodium sulphate, ammonium sulphate, magnesium sulphate and potassium chloride as salting out agents.
GB3203245A 1945-11-27 1945-11-27 Improvements in and relating to the purification of penicillin salts Expired GB604563A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB3203245A GB604563A (en) 1945-11-27 1945-11-27 Improvements in and relating to the purification of penicillin salts

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3203245A GB604563A (en) 1945-11-27 1945-11-27 Improvements in and relating to the purification of penicillin salts

Publications (1)

Publication Number Publication Date
GB604563A true GB604563A (en) 1948-07-06

Family

ID=10332046

Family Applications (1)

Application Number Title Priority Date Filing Date
GB3203245A Expired GB604563A (en) 1945-11-27 1945-11-27 Improvements in and relating to the purification of penicillin salts

Country Status (1)

Country Link
GB (1) GB604563A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2578537A (en) * 1949-12-08 1951-12-11 Bristol Lab Inc Amine salt of penicillin
US2578536A (en) * 1949-12-08 1951-12-11 Bristol Lab Inc Emetine penicillin
US2579185A (en) * 1949-12-08 1951-12-18 Bristol Lab Inc Amine salt of penicillin
US2585239A (en) * 1949-12-28 1952-02-12 Bristol Lab Inc Amine salt of penicillin

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2578537A (en) * 1949-12-08 1951-12-11 Bristol Lab Inc Amine salt of penicillin
US2578536A (en) * 1949-12-08 1951-12-11 Bristol Lab Inc Emetine penicillin
US2579185A (en) * 1949-12-08 1951-12-18 Bristol Lab Inc Amine salt of penicillin
US2585239A (en) * 1949-12-28 1952-02-12 Bristol Lab Inc Amine salt of penicillin

Similar Documents

Publication Publication Date Title
GB604563A (en) Improvements in and relating to the purification of penicillin salts
US2156242A (en) Ergot derivative and process of obtaining it
SU645581A3 (en) Method of obtaining d-2-halogen-6-methyl-8-cyanomethyl- or d-2-halogen-6-methyl-8-carboxamidomethylergolines
US3232942A (en) 1-substituted (+)-lysergol
US2861074A (en) Substituted hydroxyergolenes
NO118975B (en)
US2460240A (en) Resolution of racemic alpha hydroxy beta, beta dimethyl gamma butyrolactone
US2265217A (en) D - lysergic acid -
US2265207A (en) D-lysergic acid - d - l-bjtdroxybutyl
DE1210861B (en) Process for the preparation of 7-aminocephalosporaneane derivatives
DE1065422B (en) Process for the production of lysergic acid, its N-derivatives and esters
Labriola et al. Studies in argentine plants. XI. The partial structure of erysovine, erysodine, and erysopine
US2557762A (en) Long chain tertiary alkyl aminepenicillin salts and preparation thereof
Deulofeu et al. Studies on argentine plants. VIII. The alkaloids of erythrina crista galli. Chromatographic separation of erythratine and erysodine
US2983736A (en) Process for the preparation of 20-alkylamino steroid derivatives and novel 20-alkylamino steroid derivatives prepared thereby
US2538963A (en) Preparation of cupric d-penicilloate-g
US3642788A (en) Racemic and optically active 6h 7h-cis-7-amino-desacetylcephalosporanic acid derivatives and process
US2414070A (en) Porphyrin purification
US3231571A (en) Synthesis of 7-aminocephalosporanic acid intermediates
US3846434A (en) Process for obtaining a germine adduct from germine values
US3020295A (en) Therapeutic 4-hydroxy-19-nortestosterone-17-cyclopentyl-propionate and its process of preparation and its application
US3067215A (en) Production of 17beta-alkyl ethers of 16-keto-17beta-hydroxy steroids
US3383383A (en) Penicillanic acid derivatives
US3120528A (en) Derivatives of 17-ketoyohimbane alkaloids and process therefor
US2933501A (en) Scbpine ethers